June 09, 2026
Life Science Magazines About Us Contact Us
Life Science Newswire Service™ (LS)
Submit a Press Release
  • Analytical chemistry
  • Business
  • Biomanufacturing & bioprocessing
  • Biotechnology
  • Diagnostics
  • Drug development
  • More News
    • Environmental Science
    • Food & beverage
    • Forensic science
    • Healthcare
    • Hospitals
    • Lab tools
    • Materials science
    • Microbiology
    • Nanotechnology
    • Pharma & Biopharma
    • Pharmacy
    • Veterinary
    • Water Management
  • Press Releases
Reading: PTO Defends its Recent Policy Changes Regarding Discretionary Denials
Share
Font ResizerAa
Life Science Newswire Service™ (LS)Life Science Newswire Service™ (LS)
Search
  • Business
  • Press Releases
  • Life Science Magazines
  • Life Sciences
    • Analytical chemistry
    • Biomanufacturing & bioprocessing
    • Biotechnology
    • Diagnostics
    • Drug development
    • Environmental Science
    • Food & beverage
    • Forensic science
    • Healthcare
    • Hospitals
    • Lab tools
    • Materials science
    • Microbiology
    • Nanotechnology
    • Pharma & Biopharma
    • Pharmacy
    • Veterinary
    • Water Management
  • About Us
  • Contact Us
  • Submit a Press Release
LS Newswire Service™ is part of GroupWeb Media Network. © 2025 GroupWeb Media LLC
Life Science Newswire Service™ (LS) > Blog > Life Sciences > Biotechnology > PTO Defends its Recent Policy Changes Regarding Discretionary Denials
Biotechnology

PTO Defends its Recent Policy Changes Regarding Discretionary Denials

By Newsroom
Last updated: December 28, 2025
1 Min Read
Share


In the past few months, the U.S. Patent and Trademark Office (“PTO”) Acting Director has made substantial changes to the process for, and factors considered in, exercising discretion to deny institution of an inter partes review (“IPR”) petition. We have discussed these changes and recent decisions in prior blogs. Now, the PTO is facing legal challenges stemming from these policy changes. In one pertinent example, SAP America, Inc. filed a Petition for Writ of Mandamus to the Federal Circuit resulting from the PTO’s discretionary denial of its IPR petition, challenging the PTO Acting Director’s authority to enforce these new policies.

On…



Source link

Share This Article
Facebook Email Copy Link Print

HOT NEWS

Key Takeaways from CANECT 2025

Environmental Science
June 6, 2025

High-Throughput RT-qPCR and Transcriptomics: Powering the…

Download this free webinar on-demand to learn more. Innovative mRNA-modulating strategies are opening new possibilities…

June 8, 2026

تُظهر الدراسة أن وجبة الإفطار الغنية بالجوز من الممكن أن تساعد في تعزيز قوة دماغك

California Walnut كما أظهر بحثٌ جديد أن تناول الجوز في وجبة الإفطار يمكن أن يحسّن…

April 5, 2025

Arab Newswire Provides Press Release Distribution in Arabic

Arab Newswire - Press release distribution to media in MENA/GCC Regions Newswire expands reach with…

April 5, 2025

YOU MAY ALSO LIKE

Federal Circuit Revolutionizes Country of Origin Analysis for Pharmaceuticals

The Federal Circuit Court of Appeals has just rejected the longstanding U.S. government position that the country of origin of…

Biotechnology
April 5, 2025

Patent Litigation and the Rise of Quantum Computing: What to Watch for in the Next Decade

A recent Patent Trial and Appeal Board decision related to hybrid quantum computing paves the way for more quantum computing-related…

Biotechnology
April 19, 2025

Patent Office Releases Role of AI in Inventorship Determinations |

In February, the PTO released “Inventorship Guidance for AI-assisted Inventions (89 CFR 10043) and noted that the Office will issue…

Biotechnology
April 5, 2025

Is the Patent Eligibility Act a Panacea for Claims to Diagnostics? |

On January 23, the Subcommittee on Intellectual Property held a hearing in which the members of the committee heard testimony…

Biotechnology
April 5, 2025
Life Science Newswire Service™ (LS)

Contact Us

  • Whatsapp: +1 832-716-2363
  • Skype: Groupwebmedia
  • Telegram: Groupwebmedia

Share Us

About Us

Life Science Newswire Services (LS)™ aggregates, publishes and distributed news about the Life Science industry. In association with EmailWire, LS provides press release distribution services in the Life Science sector. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. For more information, contact us.

Categories

Analytical chemistry
Business
Biomanufacturing & bioprocessing
Biotechnology
Diagnostics
Drug development
Environmental Science
Food & beverage
Forensic science
Healthcare
Hospitals
Lab tools
Materials science
Microbiology
Nanotechnology
Pharma & Biopharma
Pharmacy
Veterinary
Water Management
Life Science Magazines
Press Releases

Recent News

High-Throughput RT-qPCR and Transcriptomics: Powering the…
June 8, 2026
Saudi Arabia Welcomes Its First Dedicated InsurTech Innovation Studio
June 8, 2026
Retatrutide eases sleep apnea and knee arthritis in new Phase 3 data, extending Lilly’s obesity lead over Novo
June 7, 2026
ACS Catalysis, JOC, OL, Organometallics, and OPR&D Announce the 2026 Award Lectureships
June 7, 2026

Life Science Magazines

High-Throughput RT-qPCR and Transcriptomics: Powering the…
June 8, 2026
AI in the EHR: What's in Use Today, What's Emerging, and How…
June 5, 2026
Human Cell-Based New-Approach Methodologies in Cancer Research
June 5, 2026
The Future of Pancreatic Cancer Trials May Not Be Randomized
June 5, 2026

LS Newswire Service™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC

Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?